3.11
price down icon0.96%   -0.03
pre-market  Vorhandelsmarkt:  3.11  
loading

Finanzdaten der Akebia Therapeutics Inc-Aktie (AKBA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
8.96%
62.47
57.34 46.50 37.43 43.65
Cost Of Revenue
30.09%
9.919
7.625 20.36 14.16 17.05
Gross Profit
5.72%
52.55
49.71 26.13 23.27 26.60
Operating Expenses
6.26%
38.46
36.20 40.44 35.77 35.33
Benefits Costs and Expenses
21.48%
62.23
51.22 69.30 57.47 52.23
Costs And Expenses
21.48%
62.23
51.22 69.30 57.47 52.23
Operating Income/Loss
4.25%
14.09
13.51 -14.31 -12.51 -8.725
Income/Loss From Continuing Operations Before Tax
95.96%
0.247
6.112 -22.80 -20.04 -8.582
Income/Loss From Continuing Operations After Tax
95.96%
0.247
6.112 -22.80 -20.04 -8.582
Net Income/Loss
95.96%
0.247
6.112 -22.80 -20.04 -8.582
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
11.49%
262.57
235.50 2.603 210.35 209.71
Diluted Average Shares
12.21%
271.10
241.60 2.603 210.35 209.71
Basic Earnings Per Share
100.00%
-
0.03 -0.11 -0.10 -0.04
Diluted Earnings Per Share
100.00%
-
0.03 -0.11 -0.10 -0.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$29.40
price up icon 1.48%
$17.85
price down icon 2.72%
drug_manufacturers_specialty_generic RDY
$14.12
price down icon 0.56%
$10.56
price up icon 0.09%
$141.92
price up icon 1.66%
$404.81
price up icon 32.83%
Kapitalisierung:     |  Volumen (24h):